Optimal treatment of drug resistant hypertension.
Phase of Trial: Phase IV
Latest Information Update: 06 Jul 2017
At a glance
- Drugs Doxazosin (Primary) ; Bisoprolol; Spironolactone
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms PATHWAY-2
- 10 Jun 2017 Biomarkers information updated
- 16 Feb 2016 Results published in the Annals of Internal Medicine
- 26 Jul 2015 Status changed from active, no longer recruiting to completed as reported by United Kingdom Clinical Research Network record.